&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; Today, 19:51

Asyad Group Expands Its Global Footprint with the Acquisition of a Controlling Stake in Uzbekistan’s Logistics Platforms, Advancing Trade Corridors & Regional Connectivity Across Central Asia
Tamika Gonzalez

Notified -

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2026-06-01, 01:29

UGRO: urban-gro, Inc. (Nasdaq: UGRO) Announces Lanka Premier League Season 6 Player Auction Set for June 1, 2026 @ 5:00 AM EDT (2:30 PM Colombo Time)
Tamika Gonzalez

Notified -

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2026-05-28, 18:00

Octave Intelligence plc Listed on Nasdaq New York
Tamika Gonzalez

Notified -

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2026-05-06, 23:00

Iveco Group Calls the Annual General Meeting
Tamika Gonzalez

Notified -

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2026-04-30, 19:30

Teva’s 2025 Healthy Future Report Highlights Environmental and Access to Medicines Progress, Including Meeting All Sustainability-Linked Bond Targets
Tamika Gonzalez

Notified -

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2026-04-30, 12:57

PU Prime Bridges the Gap Between Knowledge and Success with Launch of Interactive “PU Community” Platform
Tamika Gonzalez

Notified -

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2026-04-21, 04:00

Junshi Biosciences Presents Results from JS207 (PD-1/VEGF BsAb) Phase 2 Combo Studies and JS212 (EGFR/HER3 ADC) FIH Phase 1/2 Study at AACR 2026
Tamika Gonzalez

Notified -

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2026-04-13, 21:00

Bitget Launches New Pre-IPO Product With SpaceX as First Listing
Tamika Gonzalez

Notified -

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2026-04-08, 05:54

AliveCor Expands AI-Powered 12-lead Cardiac Diagnostics to Vietnam, Advancing Access to Early Detection and Modernized Cardiac Care
Tamika Gonzalez

Notified -

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2026-03-25, 23:15

Io Therapeutics, Inc. announces publication in Scientific Reports – Nature, of studies showing synergistic efficacy of its RXR agonist IRX4204 with the standard of care drug lenalidomide against multiple myeloma.
Tamika Gonzalez

Notified -

Popular Posts